Influenza vaccine effectiveness against hospitalizations associated with influenza a in Hong Kong children aged 9 months to 17 years, 2024/25

IF 2.2 Q3 IMMUNOLOGY
Caitriona Murphy , Mike Y.W. Kwan , Eunice L.Y. Chan , Joshua S.C. Wong , Sheena G. Sullivan , Malik Peiris , Benjamin J. Cowling , So-Lun Lee
{"title":"Influenza vaccine effectiveness against hospitalizations associated with influenza a in Hong Kong children aged 9 months to 17 years, 2024/25","authors":"Caitriona Murphy ,&nbsp;Mike Y.W. Kwan ,&nbsp;Eunice L.Y. Chan ,&nbsp;Joshua S.C. Wong ,&nbsp;Sheena G. Sullivan ,&nbsp;Malik Peiris ,&nbsp;Benjamin J. Cowling ,&nbsp;So-Lun Lee","doi":"10.1016/j.jvacx.2025.100710","DOIUrl":null,"url":null,"abstract":"<div><div>Influenza began circulating in Hong Kong in mid-December 2024. As of 12 March 2025, 1279 children were enrolled in a prospective test negative study for influenza vaccine effectiveness (VE). Among 209 influenza<strong>-</strong>positive cases, 71 % had influenza A(H1N1), 11 % had influenza A(H3N2), 3 % had influenza A with unknown subtype, and 15 % had influenza B. Among the test-negative controls, 53 % had received influenza vaccination since August 2024. End of the winter season VE estimates against hospitalization associated with influenza A(H1N1) was 64.8 % (95 % CI: 38.1 % to 80.3 %) and for influenza A(H3N2) was 59.9 % (95 % CI: −42.0 % to 89.6 %). These findings indicate that influenza vaccination provided protection against hospitalization for influenza A(H1N1) and A(H3N2) in children, highlighting the importance of continued vaccination efforts in Hong Kong.</div></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"26 ","pages":"Article 100710"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136225001044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Influenza began circulating in Hong Kong in mid-December 2024. As of 12 March 2025, 1279 children were enrolled in a prospective test negative study for influenza vaccine effectiveness (VE). Among 209 influenza-positive cases, 71 % had influenza A(H1N1), 11 % had influenza A(H3N2), 3 % had influenza A with unknown subtype, and 15 % had influenza B. Among the test-negative controls, 53 % had received influenza vaccination since August 2024. End of the winter season VE estimates against hospitalization associated with influenza A(H1N1) was 64.8 % (95 % CI: 38.1 % to 80.3 %) and for influenza A(H3N2) was 59.9 % (95 % CI: −42.0 % to 89.6 %). These findings indicate that influenza vaccination provided protection against hospitalization for influenza A(H1N1) and A(H3N2) in children, highlighting the importance of continued vaccination efforts in Hong Kong.
流感疫苗在香港9个月至17岁儿童预防甲型流感相关住院的有效性,2014 /25
流感于2024年12月中旬开始在香港传播。截至2025年3月12日,1279名儿童被纳入流感疫苗有效性(VE)的前瞻性试验阴性研究。在209例流感阳性病例中,71%感染甲型H1N1流感,11%感染甲型H3N2流感,3%感染未知亚型甲型流感,15%感染乙型流感。在检测阴性对照中,53%自2024年8月以来接种了流感疫苗。冬季结束时与甲型H1N1流感相关的住院率的VE估计为64.8% (95% CI: 38.1%至80.3%),与甲型H3N2流感相关的住院率为59.9% (95% CI: - 42.0%至89.6%)。这些研究结果显示,接种流感疫苗可防止儿童因甲型H1N1流感和甲型H3N2流感而住院,突显香港继续接种疫苗的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信